Results 171 to 180 of about 2,069,801 (345)

Ensuring access to essential services : demand-side housing subsidies [PDF]

open access: yes
This paper examines the strengths and weaknesses of demand-side subsidy approaches for improving poor households'access to housing services. It begins with a discussion of the rationale for stand-alone housing assistance programs, and a description of ...
Katsura, Harold M., Romanik, Clare T.
core  

Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li   +10 more
wiley   +1 more source

Editorial: Demand side management in microgrids

open access: yesFrontiers in Energy Research
Sumit Kumar Jha   +4 more
doaj   +1 more source

Normal‐Appearing White Matter Injury Mediates Chronic Deep Venous Hypoxia and Disease Progression in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang   +8 more
wiley   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

WILLINGNESS TO PAY FOR DRINKING WATER CONNECTIONS:THE CASE OF LARESTAN, IRAN [PDF]

open access: yes
Water scarcity in Iran has reached a level that calls for the attention of all stakeholders including water consumers. While government as water distributor has made significant efforts in managing water at the supply side, an annual average rainfall of ...
Amir Nejad, Javad Pakdin, Mohsen Mehrara
core  

Home - About - Disclaimer - Privacy